Table 2.
NR | Mouse model | Cell type | Bone phenotype | Bone mineral density | Bone resorption | Bone formation |
---|---|---|---|---|---|---|
RXR | aRxra−/− [64] | Systemic | – | – | – | – |
Rxrb−/− [65] | Systemic | Normal | NA | NA | NA | |
Rxrg−/− [66] | Systemic | Normal | NA | NA | NA | |
Mx1-Cre/Rxrafl/flbfl/fl [8] | Osteoclast lineage | Increased bone mass |
Male ↑ Female → |
↓ | → | |
PPAR | Ppara−/− [110] | Systemic | Normal | → | → | → |
PpardSox2-cKO [74] | Systemic (except placenta) | Osteopenia | ↓ | ↑ | → | |
Pparg+/− [81] | Systemic |
Increased bone mass Osteopetrosis |
↑ | → | ↑ | |
Tie2Cre/Ppargfl/fl [82] | Osteoclast lineage | Increased bone mass | ↑ | ↓ | → | |
LXR | Lxra−/− [60] | Systemic | Increased bone mass | Male → Female ↑ | ↓ | → |
Lxrb−/− [60] | Systemic | Normal | → | ↓ | ↑ | |
Lxrab−/− [60] | Systemic | Normal | → | → | → | |
FXR | Fxr−/− [61] | Systemic | Osteopenia |
Male ↓ Female → |
↑ | ↓ |
PXR | Pxr−/− [62] | Systemic | Osteopenia |
Male ? Female ↓ |
↑ | ↓ |
CAR | Car−/− [52] | Systemic | Increased bone mass |
Male ↑ Female → |
→ | ↑? |
Nur77 | Nurr77−/− [63] | Systemic | Osteopenia | ↓ | ↑ | → |
Nurr1 | Nurr1+/− [111] | Systemic | Normal | NA | NA | NA |
RAR | Rara−/− [75] | Systemic | Normal | → | → | → |
Rarb−/− | Systemic | Normal | NA | NA | NA | |
Rarg−/− [75] | Systemic | Osteopenia | ↓ | ↑ | ? | |
TR | TRα−/− [112] | Systemic | Osteosclerosis | ↑ | ↓ | NA |
TRb−/− [112] | Systemic | Osteoporosis | ↓ | ↑ | NA | |
VDR | VDR−/− [113, 114] | Systemic | Rickets Osteomalacia | ↓ | → | ↑ |
Col2Cre+/−VDRfl/fl [83] | Chondrocyte | Increased bone mass | ↑ | ↓ | → |
Arrows indicate increase, decrease, or no change
NA not assessed
aEmbryonically lethal